The latest ‘scary’ variant in the COVID-19 saga is named omicron.
Mainstream media is going into fearmongering overdrive, and politicians have taken steps to create a self-manufactured crisis.
Yet, South Africa hasn’t resorted to panic mode following news of the omicron variant.
Dr. Angelique Coetzee noted unusual but mild symptoms in her patients.
South African residents don’t appear to be afraid of the virus either.
The country has a relatively low COVID-19 inoculation rate and built a stockpile of unused COVID-19 jabs.
South Africa’s COVID-19 inoculation campaign came grinding to a halt, and they asked manufacturers to stop sending them additional doses.
However, something strange happened shortly after this exchange between South Africa and the vaccine manufacturers.
South Africa has asked Johnson & Johnson (JNJ.N) and Pfizer (PFE.N) to delay delivery of COVID-19 vaccines because it now has too much stock, health ministry officials said, as vaccine hesitancy slows an inoculation campaign.
South Africa asked Johnson & Johnson and Pfizer Inc. to suspend delivery of Covid-19 vaccines as it now has enough stock, an illustration of how plunging demand is undermining the country’s rollout ahead of a potential fourth wave of infections.
Africa’s most developed economy has fully protected just 35% of adults, more than six months after doses were first made available to the public. About 120,000 people received shots on Tuesday, less than half the daily peak.
“We have over 16 million doses in-country, or more than 150 days at present consumption,” Nicholas Crisp, deputy director-general of the Department of Health, said by text message Wednesday. “It makes no sense to stockpile and risk expiry when others are desperate for supplies.”
The move contrasts with the country’s position earlier in the year when the government was heavily criticized for being slow to secure vaccines ahead of a devastating mid-year surge. It also comes as most of Africa remains chronically short of doses, partly because richer countries rushed to tie up vast quantities of stock.
“It is entirely owing to hesitancy,” Crisp said. “We have plenty vaccine and capacity but hesitancy is a challenge. Unfortunately, it means that many unvaccinated people may have an unhappy festive season and will possibly result in hospitals being congested.”
According to Our World in Data, 23.8% of South Africans are fully vaccinated against COVID-19, and 28.3% have received at least one dose.
Bloomberg released their article about South Africa requesting a stoppage of COVID-19 jab deliveries on November 24th.
On November 26th, the WHO identified omicron as a “variant of concern.”
As reported by USA Today:
A COVID-19 variant spreading in South Africa was dubbed “omicron” and classified a “variant of concern” by the World Health Organization on Friday, as the U.S. and other nations reacted to the newly discovered variant with travel restrictions.
Experts with the World Health Organization met Friday to assess the variant, which appears to have a high number of mutations in the virus’ spike protein, prompting worries about how easily it will spread. While good data on the risks of omicron is likely weeks away, the organization cited early evidence suggesting an increased risk of reinfection.
The U.S. said it will restrict travel from South Africa, as well as Botswana, Zimbabwe, Namibia, Lesotho, Eswatini, Mozambique and Malawi, according to a statement from senior officials from the Biden administration.
Isn’t it odd that the latest variant was discovered in a country experiencing rampant vaccine hesitancy?
And does anyone else find it peculiar that the variant was ‘discovered’ days after said country told the pharmaceutical companies to stop sending COVID-19 jabs?
Due to a majority vaccine-hesitant population, maybe it’s not a surprise this new variant started in South Africa.
Could this be a sort of ‘punishment’ to its population for not rolling up their sleeves at the desired rate?
And let’s not discount the furious drive to administer boosters to western nations.